Comparison of efficacy of ipraglifrozine and high-dose metformin in patients with type 2 diabetes
Phase 4
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000014963
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1. treated by insulin injection 2. unstable diabetic retinopathy 3. advanced liver, renal or cardiac disease(s) 4. allergy to metformine or ipraglyfrozine 5. (possible) pregnant or breast-feeding women 6. those with severe ketosis or diabetic (pre)coma 7. those with severe infection or trauma, or before/after sugery 8. those who are inappropriated for the present study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method